Fibrocell Science to Present at BioCentury NewsMakers of the Biotech Industry Conference

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today announced that David Pernock, chairman and chief executive officer of Fibrocell Science will present at the BioCentury NewsMakers in the Biotech Industry conference at 9:30 a.m. EDT on Friday, September 26, 2014, in New York City. Mr. Pernock will discuss the company’s autologous fibroblast technology, and its therapeutic candidates in development focused on genetically-modified personalized biologics.